Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program
To assess risk of developing a second benign brain tumor in a nationwide population of cancer survivors.
We evaluated the risk of developing second benign brain tumors among 2,038,074 1-year minimum cancer survivors compared to expected risk in the general population between 1973 and 2007 in nine population-based cancer registries in the NCI’s surveillance, epidemiology, and end results program. Excess risk was estimated using standardized incidence ratios (SIRs) for all second benign brain tumors and specifically for second meningiomas and acoustic neuromas diagnosed during 2004–2008.
1,025 patients were diagnosed with a second primary benign brain tumor, of which second meningiomas composed the majority (n = 745). Statistically significant increases in risk of developing a second meningioma compared to the general population were observed following first cancers of the brain [SIR = 19.82; 95 % confidence interval (CI) 13.88–27.44], other central nervous system (CNS) (SIR = 9.54; CI 3.10–22.27), thyroid (SIR = 2.05; CI 1.47–2.79), prostate (SIR = 1.21; CI 1.02–1.43), and acute lymphocytic leukemia (ALL) (SIR = 42.4; CI 23.18–71.13). Statistically significant decreases in risk were observed following first cancers of the uterine corpus (SIR = 0.63; CI 0.42–0.91) and colon (SIR = 0.56; CI 0.37–0.82). Differences in risk between patients initially treated with radiotherapy versus non-irradiated patients were statistically significant for second meningioma after primary cancers of the brain (p Het < 0.001) and ALL (p Het = 0.02). No statistically significant increased risks were detected for second acoustic neuromas (n = 114) following any first primary tumor.
Risk of second benign brain tumors, particularly meningioma, is increased following first primary cancers of the brain/CNS, thyroid, prostate, and ALL. Radiation exposure likely contributes to these excess risks.
KeywordsMeningioma Radiotherapy SEER Brain neoplasm Second primary neoplasm
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Howlader NNA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (2011) SEER cancer statistics review, 1975–2008, National Cancer Institute http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission
- 2.Ng AK, Travis LB (2008) Subsequent malignant neoplasms in cancer survivors. Cancer J 14(6):429–434. doi: 10.1097/PPO.0b013e31818d87700130404-200811000-00014 PubMedCrossRefGoogle Scholar
- 4.Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA, Edwards BK (2011) Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 103(9):714–736. doi: 10.1093/jnci/djr077 PubMedCentralPubMedCrossRefGoogle Scholar
- 5.Shonka NA, Hsu SH, Yung W, Mahajan A, Prabhu S (2011) Chapter 37. Tumors of the central nervous system. In: Kantarjian HM, Wolff RA, Koller CA (eds) The MD Anderson manual of medical oncology, 2 edn. McGraw-Hill, New YorkGoogle Scholar
- 7.Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neurooncology 4(4):278–299Google Scholar
- 8.Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il’yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA (2008) Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer 113(7 Suppl):1953–1968. doi: 10.1002/cncr.23741 PubMedCentralPubMedCrossRefGoogle Scholar
- 13.Cahill KS, Claus EB (2011) Treatment and survival of patients with nonmalignant intracranial meningioma: results from the surveillance, epidemiology, and end results program of the National Cancer Institute. J Neurosurg 115(2):259–267. doi: 10.3171/2011.3.JNS101748 PubMedCentralPubMedCrossRefGoogle Scholar
- 14.Surveillance Research Program, National Cancer Institute SEER*Stat software (http://seer.cancer.gov/seerstat) version 8.1.2
- 16.Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E (2011) Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12(4):353–360. doi: 10.1016/S1470-2045(11)70061-4 PubMedCrossRefGoogle Scholar
- 17.Bhatia S (2005) Cancer survivorship–pediatric issues. Hematology/the Education Program of the American Society of Hematology American Society of Hematology Education Program: 507–515. doi: 10.1182/asheducation-2005.1.507
- 18.Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD (2006) New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 98(21):1528–1537. doi: 10.1093/jnci/djj411 PubMedCrossRefGoogle Scholar
- 20.Taylor AJ, Little MP, Winter DL, Sugden E, Ellison DW, Stiller CA, Stovall M, Frobisher C, Lancashire ER, Reulen RC, Hawkins MM (2010) Population-based risks of CNS tumors in survivors of childhood cancer: the British childhood cancer survivor study. J Clin Oncol 28(36):5287–5293. doi: 10.1200/JCO.2009.27.0090 PubMedCrossRefGoogle Scholar
- 26.Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M Family and personal medical history and risk of meningioma. J Neurosurg doi: 10.3171/2011.6.JNS11129
- 27.Sughrue ME, Kane AJ, Shangari G, Parsa AT, Berger MS, McDermott MW Prevalence of previous extracranial malignancies in a series of 1228 patients presenting with meningioma. J Neurosurg 113 (5):1115–1121. doi: 10.3171/2010.3.JNS091975
- 31.Rao G, Giordano SH, Liu J, McCutcheon IE (2009) The association of breast cancer and meningioma in men and women. Neurosurgery 65 (3):483–489; discussion 489. doi: 10.1227/01.NEU.0000350876.91495.E000006123-200909000-00016 Google Scholar
- 34.Tang H, Quertermous T, Rodriguez B, Kardia SL, Zhu X, Brown A, Pankow JS, Province MA, Hunt SC, Boerwinkle E, Schork NJ, Risch NJ (2005) Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet 76(2):268–275. doi: 10.1086/427888 PubMedCentralPubMedCrossRefGoogle Scholar
- 35.Risch N, Burchard E, Ziv E, Tang H (2002) Categorization of humans in biomedical research: genes, race and disease. Genome Biol 3 (7): comment 2007Google Scholar